Estados Unidos

Helicopter money is coming, and once deployed, will prove to be much more successful than most people imagine. Stay long Japanese and German inflation swaps. USD/JPY and EUR/USD are ultimately likely to reach 140 and 0.9, respectively, over the next two years. The U.S. economy will remain resilient enough to make helicopter money unnecessary but a strengthening dollar will greatly curtail the ability of the Fed to raise rates. Investors should overweight Treasurys relative to bunds and JGBs. Helicopter money will benefit gold as well as the beleaguered European and Japanese stock markets.

The Fed is accentuating bearish dynamics for the dollar over the next three to six months. The upcoming National Congress of the Communist Party of China provides Chinese authorities with an incentive to ramp up stimulus this year. The new Treasury semi-annual report pre-empts meaningful direct interventions to soften the yen. More than just Brexit risk is weighing on the pound.

The overall tech sector has been under pressure as a consequence of shoddy profits. We do not expect any imminent reprieve, particularly within the heavyweight S&P computer hardware, storage and peripherals index. This group is highly sensitive to swings in capital spending budgets. The latter are under pressure from a narrowing in the gap between the return on and cost of capital in the overall business sector. New orders for computer hardware products have dropped into the contraction zone, warning of potential shrinkage in top-line growth. To make matters worse, wage inflations has surged in recent quarters. That is a recipe for productivity disappointment. Until overall business sector profits are poised to recovery on a sustained basis, demand for hardware is likely to stay on its heels. We reiterate our underweight position. The ticker symbols for the stocks in this index are: BLBG: S5THSP - AAPL, EMC, HPE, HPQ, SNDK, WDC, NTAP, STX.

The insurance industry is battling generationally low interest rates, which has created a deep undercurrent of pessimism toward related equities. That is borne out by extremely cheap valuations, as measured by relative price/book value ratios (bottom panel). However, such a low expectations hurdle should be easily surpassed. After a prolonged slump, consumers are allocating a rising share of spending to insurance products, consistent with increased housing turnover and buoyant vehicle sales. In turn, insurance companies have been able to lift premiums at a solid rate. This shift in spending patterns bodes well for profit outperformance, and ultimately, a re-rating in dirt cheap relative valuations. The surge in our insurance relative advance/decline line heralds share price outperformance and we reiterate our high-conviction overweight. The ticker symbols for the stocks in this index are: BLBG: S5INSU.

The pace of U.S. oil supply destruction accelerated at the end of April, as yoy losses increased to 470 thousand barrels per day (Mb/d) for the week ended April 29.

Air freight stocks have been unable to gather speed during the most recent bout of overall market strength and bid under risky assets, reflecting long-term pressure on valuation multiples. Persistently high business inventories mean that companies are not under pressure to use rapid delivery services to fulfill customer requirements. Indeed, when inventories are tight and bottlenecks exist, demand for high margin freight services increase as businesses rush to catch up. This dynamic acts as a weight on valuation multiples for air freight companies, and is unlikely to soon change based on the downbeat message regarding global trade from the IFO survey (third panel). With global trade volumes barely growing and leading indicators warning of downside risks, the message is that air freight profits will have difficulty meeting lofty expectations, particularly now that oil prices are no longer falling in support of profit margins. We are underweight this index. The ticker symbols for the stocks in this index are: BLBG: S5AIRFX - UPS, FDX, CHRW, EXPD.

Pharmaceutical stocks are trading at historically cheap relative valuations on the back of political pressure on a few high-profile specialty pharma companies. We see this as an opportunity to add to positions in the more traditional pharma space. Our concerns about excessive drug pricing will only materialize when there is evidence that consumption patterns are changing. So far, there is scant evidence of higher prices choking consumption. Consumer spending on drugs is hitting new highs. That is true in both real and nominal terms, underscoring that higher outlays are not simply a reflection of rising drug prices. While the growth rate of drug consumption may slow, pent up demand from years of medical procedure deferral following the Great Recession will take time to play out. As such, soaring pharmaceutical shipments should be interpreted as demand-driven. Consequently, we expect profit outperformance to persist, and drive a sustained recovery in relative share prices. The ticker symbols for the stocks in this index are: BLBG: S5PHAR - JNJ, PFE, MRK, BMY, AGN, LLY, ZTS, MYL, PRGO, MNK, ENDP.

Bank Credit Analyst

The end of the Debt Supercycle will be a key theme influencing economic and financial trends for many years to come. Its hallmark will remain the inability of central banks to engineer a new credit cycle, despite extremely low interest rates. China is one of the few remaining countries where the Debt Supercycle has yet to end, and history suggests the catalyst for a turning point will be a financial crisis.

The reflation rally continues. Despite our bearish outlook for the year, we think the risks of the current rally lie to the upside given China's redoubling of stimulus at the expense of reform. Populist troubles are picking up in Europe, but we maintain our positive structural view and note that the migration crisis is slackening. Rather, the greatest risks of populism continue to flourish in the Anglo-Saxon world with Brexit and Trump.

Informe especial

The U.S. dollar has fallen to almost 5% below its 2016 peak. In this <i>Special Report</i> we explore the impact of a weaker dollar on key U.S. fixed income markets.